Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Vonoprazan Versus Lansoprazole in Systemic Sclerosis Patients with Erosive Esophagitis
TCTR20240916012Phase 3Unknown
- Sponsor
- Witsarut Manasirisuk
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in erosive esophagitis (EE) comparing Vonoprazan with Lansoprazole (2 arms). Status: unknown.
02
Drugs
vonoprazanlansoprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on TCTR20240916012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240916012.